Tandem Diabetes Care Files 8-K
Ticker: TNDM · Form: 8-K · Filed: Apr 1, 2024 · CIK: 1438133
| Field | Detail |
|---|---|
| Company | Tandem Diabetes Care Inc (TNDM) |
| Form Type | 8-K |
| Filed Date | Apr 1, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, financials
TL;DR
Tandem Diabetes Care filed an 8-K, mostly financial docs. No major news.
AI Summary
On March 21, 2024, Tandem Diabetes Care, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material events or other significant business updates detailed in the provided text.
Why It Matters
This filing indicates Tandem Diabetes Care is submitting required financial statements and exhibits to the SEC, a routine but necessary part of public company compliance.
Risk Assessment
Risk Level: low — The filing appears to be a routine submission of financial statements and exhibits, not indicating any immediate business risks.
Key Players & Entities
- Tandem Diabetes Care, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- 20-4327508 (tax_id) — I.R.S. Employer Identification No.
- 12400 High Bluff Drive (address) — Principal executive offices
- San Diego (city) — Principal executive offices
- California (state) — Principal executive offices
- 92130 (zip_code) — Principal executive offices
- 858-366-6900 (phone_number) — Registrant's telephone number
- March 21, 2024 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report financial statements and exhibits as of March 21, 2024.
What is the exact name of the registrant?
The exact name of the registrant is Tandem Diabetes Care, Inc.
In which state was Tandem Diabetes Care, Inc. incorporated?
Tandem Diabetes Care, Inc. was incorporated in Delaware.
What is the address of Tandem Diabetes Care, Inc.'s principal executive offices?
The address of Tandem Diabetes Care, Inc.'s principal executive offices is 12400 High Bluff Drive, San Diego, California 92130.
What is the telephone number for Tandem Diabetes Care, Inc.?
The telephone number for Tandem Diabetes Care, Inc. is (858) 366-6900.
Filing Stats: 422 words · 2 min read · ~1 pages · Grade level 9.9 · Accepted 2024-04-01 16:33:36
Key Financial Figures
- $0.001 — ich Registered Common Stock, par value $0.001 per share TNDM NASDAQ Global Market I
Filing Documents
- tndm-20240321.htm (8-K) — 23KB
- 0001438133-24-000047.txt ( ) — 144KB
- tndm-20240321.xsd (EX-101.SCH) — 2KB
- tndm-20240321_lab.xml (EX-101.LAB) — 21KB
- tndm-20240321_pre.xml (EX-101.PRE) — 12KB
- tndm-20240321_htm.xml (XML) — 3KB
01 Other Events
Item 8.01 Other Events. On March 21, 2024, the U.S. Food and Drug Administration cleared our 510(k) application for our Tandem Mobi insulin pump with an expanded pediatric indication for use in individuals two years of age and older.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Number Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Tandem Diabetes Care, Inc. By: /s/ SHANNON M. HANSEN Shannon M. Hansen Chief Legal, Privacy & Compliance Officer; Secretary Date: April 1, 2024 3